Who Benefits Most from Adjuvant Durvalumab after Chemoradiotherapy for Non-Small Cell Lung Cancer?
Saved in:
| Title: | Who Benefits Most from Adjuvant Durvalumab after Chemoradiotherapy for Non-Small Cell Lung Cancer? |
|---|---|
| Authors: | Ohri, N.1 (AUTHOR), Halmos, B.2 (AUTHOR), Bodner III, W.R.1 (AUTHOR), Cheng, H.2 (AUTHOR), Garg, M.K.1 (AUTHOR), Gucalp, R.2 (AUTHOR), Guha, C.1 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe85-e86. 2p. |
| Subjects: | Non-small-cell lung carcinoma, Chemoradiotherapy, Rectal cancer |
| Database: | Engineering Source |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: egs DbLabel: Engineering Source An: 146684886 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Who Benefits Most from Adjuvant Durvalumab after Chemoradiotherapy for Non-Small Cell Lung Cancer? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ohri%2C+N%2E%22">Ohri, N.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Halmos%2C+B%2E%22">Halmos, B.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bodner+III%2C+W%2ER%2E%22">Bodner III, W.R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheng%2C+H%2E%22">Cheng, H.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garg%2C+M%2EK%2E%22">Garg, M.K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gucalp%2C+R%2E%22">Gucalp, R.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guha%2C+C%2E%22">Guha, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22International+Journal+of+Radiation+Oncology%2C+Biology%2C+Physics%22">International Journal of Radiation Oncology, Biology, Physics</searchLink>. 2020 Supplement, Vol. 108 Issue 3, pe85-e86. 2p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Non-small-cell+lung+carcinoma%22">Non-small-cell lung carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22Chemoradiotherapy%22">Chemoradiotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Rectal+cancer%22">Rectal cancer</searchLink> |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=146684886 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ijrobp.2020.07.1179 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: e85 Subjects: – SubjectFull: Non-small-cell lung carcinoma Type: general – SubjectFull: Chemoradiotherapy Type: general – SubjectFull: Rectal cancer Type: general Titles: – TitleFull: Who Benefits Most from Adjuvant Durvalumab after Chemoradiotherapy for Non-Small Cell Lung Cancer? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ohri, N. – PersonEntity: Name: NameFull: Halmos, B. – PersonEntity: Name: NameFull: Bodner III, W.R. – PersonEntity: Name: NameFull: Cheng, H. – PersonEntity: Name: NameFull: Garg, M.K. – PersonEntity: Name: NameFull: Gucalp, R. – PersonEntity: Name: NameFull: Guha, C. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 11 Text: 2020 Supplement Type: published Y: 2020 Identifiers: – Type: issn-print Value: 03603016 Numbering: – Type: volume Value: 108 – Type: issue Value: 3 Titles: – TitleFull: International Journal of Radiation Oncology, Biology, Physics Type: main |
| ResultId | 1 |
